Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.2898 +0.0198 (+7.33%)
Official Closing Price Updated: 6:30 PM EDT, Apr 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
420 with CNW — Maryland Reports $10M Sales on First Weekend After Launching Retail Cannabis Market
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — State-Level Cannabis Regulation Causes Confusion as Federal Prohibition Persists
Via Investor Brand Network
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — State-Level Cannabis Regulation Causes Confusion as Federal Prohibition Persists
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Lawmakers Author Amendments to Change Cannabis Rules for Security Personnel, Military Recruits
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — Lawmakers Author Amendments to Change Cannabis Rules for Security Personnel, Military Recruits
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
IGC Raises $3M Via Private Placement With Asset Management Firm Bradbury
IGC Pharma, Inc. (AMEX: IGC) bagged a strategic investment  
Via Benzinga
420 with CNW — Missouri Conducts Outreach Events as Cannabis Microbusiness Lottery Looms
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — Missouri Conducts Outreach Events as Cannabis Microbusiness Lottery Looms
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Financial Results for Fiscal 2023
Via Investor Brand Network
Exposures Product Safety
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
IGC Pharma, Inc. (AMEX:IGC) released its financial results for the fiscal year ended March 31, 2023, revealing revenue of $911,000, an increase of 129% compared to $397,000 in fiscal year 2022. FY 2023... 
Via Benzinga
IGC Reports Financial Results for Fiscal Year Ended March 31, 2023
From IGC Pharma, Inc.
Via Business Wire
420 with CNW — Oklahoma Cannabis Companies Sue Regulators over Proposed Fees
Via Investor Brand Network
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Oklahoma Cannabis Companies Sue Regulators over Proposed Fees
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Maryland Starts Implementing Adult-Use Cannabis Law
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Maryland Starts Implementing Adult-Use Cannabis Law
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — NBA Formally Removes Cannabis from List of Banned Substances
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — NBA Formally Removes Cannabis from List of Banned Substances
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
IGC Pharma Secures $12M Credit Facility From O-Bank To Aid Alzheimer's Research
IGC Pharma, Inc. (AMEX: IGC) has recently secured a $12 million credit from the  
Via Benzinga
BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Secures $12M Line of Credit to Strengthen Efforts in Alzheimer’s Research
Via Investor Brand Network
IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research
From IGC Pharma, Inc.
Via Business Wire
420 with CNW — Despite Ongoing Challenges, California’s Legal Cannabis Market Remains Huge
Via Investor Brand Network
Topics Cannabis Economy
Exposures Cannabis Economy
420 with CNW — Despite Ongoing Challenges, California’s Legal Cannabis Market Remains Huge
Via CannabisNewsWire
Topics Cannabis Economy
Exposures Cannabis Economy
BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces $3M Common Stock Private Placement
Via Investor Brand Network
IGC Pharma Secures $3M Via Private Placement
IGC Pharma, Inc. (AMEX:IGC) announced a strategic investment from four investment funds managed by Bradbury Asset Management (Hong Kong) Limited, an asset management firm with over $2 billion in... 
Via Benzinga
Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company. 
Via Benzinga
IGC Pharma Announces a $3 Million Private Placement of its Common Stock
From IGC Pharma, Inc.
Via Business Wire
420 with CNW — Florida AG Tells Supreme Court Cannabis Legalization Measure is Misleading to Voters
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — Florida AG Tells Supreme Court Cannabis Legalization Measure is Misleading to Voters
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Cannabis High Linked to Improved Symptoms Among Patients Using Medical Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Cannabis High Linked to Improved Symptoms Among Patients Using Medical Marijuana
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.